lyophilized powder is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20°C or below | Protect from light and moisture |
| Analytical method | RP-HPLC | Purity and identity assessment |
| Mass confirmation | Mass spectrometry | Verifies molecular mass |
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
Disease testing: Whether the sex of the fetus is male or female allows the determination of the risk of a particular X-linked recessive genetic disorder in a particular pregnancy, especially where the mother is a genetic carrier of the disorder. Preparation, for any sex-dependent aspects of parenting. Sex selection, which after preimplantation genetic diagnosis may be performed by selecting only embryos of the preferred sex, or, after post-implantation methods by performing sex-selective abortion depending on the test result and personal preference. In comparison to obstetric ultrasonography which is unreliable for sex determination in the first trimester and amniocentesis which carries a small risk of miscarriage, sampling of maternal plasma for analysis of cffDNA is without risk. The main targets in the cffDNA analysis are the gene responsible for the sex-determining region Y protein (SRY) on the Y chromosome and the DYS14 sequence.
Centre of Policy and Legal Reform (CPLR), a non-governmental think tank founded in 1996. Center for Policy Studies in Ukraine, a non-governmental think tank founded in 1994. International Centre for Policy Studies, a non-governmental think tank founded in 1994. Razumkov Centre, a non-governmental think tank founded in 1994. It carries out research of public policy in the following spheres: domestic policy; state administration; economic policy; energy; land relations; foreign policy; social policy; international and regional security; national security and defense. Transatlantic Dialogue Center, a non-governmental think tank founded in 2021.
On April 25, 2020, senior Clan del Golfo leader, Gustavo Adolfo Álvarez Téllez, who was one of Colombia's most wanted drug lords with a 580 million peso bounty for his capture, was arrested at his lavish estate in Cereté while holding a party under quarantine during the COVID-19 pandemic. Álvarez was described as the "brain" of the cartel and by this point was reported to have taken charge of the cartel's Caribbean operations. On June 26, 2020, Clan del Golfo and FARC dissidents were confirmed to be in a direct armed conflict in northern Antioquia, known as Operation Mil. Clan del Golfo, which dispatched 1,000 of its paramilitaries from Urabá, southern Córdoba, and Chocó, hoped to suppress FARC rebels in northern Antioquia and take control of the entire municipality of Ituango. On January 2, 2022, an internal fight occurred between the ELN and FARC dissidents in Arauca, leaving 23 people dead. On June 9, 2023, the Colombian government and ELN signed a six month nationwide ceasefire, which would go into effect on August 3. This came after months of peace talks in Havana. On January 19, 2025, ELN and FARC forces erupted into combat in the Catatumbo region. Around 80 people were killed, while thousands of residents fled the violence. Many schools and sports stadiums were converted into refugee shelters, and Colombia deployed 5,000 soldiers in an attempt to restore peace. Since 13 August, 2025, clashes between FARC dissidents and the Military Forces of Colombia have resulted in at least 34 deaths and a hundred more wounded.
=== Vagina === Between the years 2005 and 2008, four women with vaginal hypoplasia due to Müllerian agenesis were given regenerated vaginas. Up to eight years after the transplants, all organs have normal function and structure.
== Reactions == Thionyl tetrafluoride reacts with water to make hydrofluoric acid, sulfurofluoridic acid, and sulfuryl difluoride. Mercury can strip off fluoride to make thionyl fluoride and mercurous fluoride. Strong bases result in formation of fluoride and fluorosulfate ions. Reactions with the strong Lewis acids, such as AsF5 and SbF5, result in the formation of trifluorosulfoxonium cation [SOF3]+ and the corresponding salts [SOF3]+[AsF6]− (trifluorosulfoxonium hexafluoroarsenate(V)) and [SOF3]+[SbF6]− (trifluorosulfoxonium hexafluoroantimonate(V)), respectively.
Sources: en.wikipedia.org
The presence of this alternative pathway was first described in an SV40 virus-transformed human cell line, and based on the dynamics of the changes in telomere length, was proposed to result through recombination. However, the exact mechanism remains unclear. Elizabeth Blackburn et al. identified the upregulation of 70 genes known or suspected in cancer growth and spread through the body, and the activation of glycolysis, which enables cancer cells to rapidly use sugar to facilitate their programmed growth rate (roughly the growth rate of a fetus). Approaches to controlling telomerase and telomeres for cancer therapy include gene therapy, immunotherapy, small-molecule and signal pathway inhibitors.
1930: Mexican civil engineer Concepción Mendizábal Mendoza became the first woman in Mexico to earn a civil engineering degree. 1930: Russian botanist and geneticist Elena Barulina published the first map of the international distribution of lentils and their wild relatives, a work that became the standard reference for researchers. 1932: Michiyo Tsujimura became the first Japanese woman to earn a doctorate in agriculture. She studied at the Tokyo Imperial University, and her doctoral thesis was entitled "On the Chemical Components of Green Tea". 1933: Hungarian scientist Elizabeth Rona received the Haitinger Prize from the Austrian Academy of Sciences for her method of extracting polonium. 1933: American bacteriologist Ruth Ella Moore became the first African-American woman to receive a PhD in the natural sciences, completing her doctorate in bacteriology at Ohio State University. 1933: Egyptian medical doctor Tawhida Abdel-Rahman became the first female doctor employed by the Egyptian Government Health Ministry. 1935: French chemist Irène Joliot-Curie received the Nobel Prize in Chemistry along with Frédéric Joliot-Curie "for their synthesis of new radioactive elements". 1935: American plant hybridist Grace Sturtevant, the "First Lady of Iris", received the American Iris Society's gold medal for her lifetime's work. 1936: American entomologist Edith Patch became the first female president of the Entomological Society of America. 1936: New Zealand mycologist Kathleen Maisey Curtis was elected the first female Fellow at the Royal Society of New Zealand.
In Filipino cuisine, the noodles are called a similar name: sotanghon because of the popular dish of the same name made from them using chicken and wood ears. They are also confused with rice vermicelli, which is called bihon in the Philippines.
=== Other === The role of the circadian clock in rheumatoid arthritis suggests a correlation between an early morning rise in circulating levels of pro-inflammatory cytokines, such as interleukin-6 and painful morning joint stiffness.
Sources: en.wikipedia.org
to Cuba while he was working for it. Noriega also undertook a number of activities while nominally working for the CIA that served his own ends at the expense of the U.S. government. Journalist Frederick Kempe wrote in 1990 that Noriega had been linked to a series of bombings targeting the U.S. territory in the Panama Canal Zone during the prelude to the U.S. Presidential election in 1976 after the administration of U.S. President Gerald Ford stepped back from negotiations about the Panama Canal. The bombings highlighted to the U.S. government the difficulty of holding on to the Panama Canal Zone in the face of hostility within Panama. Kempe stated that the U.S. knew of Noriega's involvement in the bombings but decided to turn a blind eye toward them. In a December 1976 meeting with George H. W. Bush, then Director of Central Intelligence, Noriega flatly denied involvement, instead suggesting that the CIA was responsible. During negotiations for the Panama Canal treaties, the U.S. government ordered its military intelligence to wiretap Panamanian officials. Noriega discovered this operation in early 1976, and instead of making it public, bribed the U.S. agents and bought the tapes in person; the incident came to be known as the "Singing Sergeants affair". Although some intelligence officials wanted Bush to prosecute the soldiers involved, he declined, because doing so would have exposed Noriega's role in the matter. The CIA did not report this incident to either the National Security Agency or the U.S. Justice Department.
== Metabolism == Urobilin is generated from the degradation of heme, which is first degraded through biliverdin to bilirubin. Bilirubin is then excreted as bile, which is further degraded by microbes present in the large intestine to urobilinogen. The enzyme responsible for the degradation is bilirubin reductase, which was identified in 2024. Some of this remains in the large intestine, and its conversion to stercobilin gives feces their brown color. Some is reabsorbed into the bloodstream and then delivered to the kidneys. When urobilinogen is exposed to air, it is oxidized to urobilin, which has a yellow color.
== Pathophysiology == Myasthenia gravis is an autoimmune synaptopathy. The disorder occurs when the immune system malfunctions and generates antibodies that attack the body's tissues. The antibodies in MG attack a normal human protein, the nicotinic acetylcholine receptor, or a related protein called MuSK, a muscle-specific kinase. Other, less frequent antibodies are found against LRP4, agrin, and titin proteins. Human leukocyte antigen haplotypes are associated with increased susceptibility to myasthenia gravis and other autoimmune disorders. Relatives of people with myasthenia gravis have a higher percentage of other immune disorders. The thymus gland cells form part of the body's immune system. In those with myasthenia gravis, the thymus gland is large and abnormal. It sometimes contains clusters of immune cells that indicate lymphoid hyperplasia, and the thymus gland may give wrong instructions to immune cells.
Sources: en.wikipedia.org
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.
Lyophilized powder should be stored at -20°C or lower, protected from light and moisture. Reconstituted solutions are less stable and should be aliquoted to avoid freeze-thaw cycles. Always follow supplier instructions.
Variability in purity, counterion content, and residual solvents is possible. Independent testing and certificates of analysis help verify quality. Microbial contamination can occur if handling is not sterile.
No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.